NEW YORK, June 05, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Humana Inc. ("Humana" or the "Company") (NYSE: HUM). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased. On this news, Humana's stock price fell $18.20 per share, or almost 4%, t ...

NEW YORK, June 04, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Humana Inc. ("Humana" or the "Company") (NYSE: HUM) in the United States District Court for the District of Delaware on behalf of all persons and entities who purchased or otherwise acquired Humana common stock between July 27, 2022, and January 24, 2024, both dates inclusive (the "Class Period"). Investors have until Augus ...

NEW YORK, June 04, 2024 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a securities class action lawsuit has been filed in the United States District Court for the District of Delaware on behalf of all persons and entities who purchased securities of Humana Inc. ("Humana" or the "Company") (NYSE: HUM) between July 27, 2022 and January 24, 2024, inclusive (the "Class Period"). Then, on June 16, 2023, the Complaint alleges that Humana reported "higher than anticipated non-inpatient utilization t ...

The recent move indicates HUM's efforts to expand treatment options in Alabama and subsequently, strengthen its presence across the United States. With access to UAB's facilities, more individuals are likely to opt for HUM's Medicare Advantage plans. The resultant benefit of membership growth will be higher premiums, which remain the most significant top-line contributor of a health insurer. Individual Medicare Advantage premiums advanced 13.3% year over year in the first quarter. Management anticipates thi ...

LOS ANGELES, June 4, 2024 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Humana Inc. ("Humana" or "the Company") (NYSE: HUM) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between July 27, 2022 and January 24, 2024, inclusive (the "Class Period"), are encourag ...

SAN DIEGO, June 03, 2024 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that the Humana class action lawsuit seeks to represent purchasers or acquirers of Humana Inc. (NYSE: HUM) common stock between July 27, 2022 and January 24, 2024, inclusive (the "Class Period"). Captioned Iron Workers Local 401 Annuity Fund v. Humana Inc., No. 24-cv-00655 (D. Del.), the Humana class action lawsuit charges Humana and certain of Humana's top executives with violations of the Securities Exchange Act of 193 ...

A month has gone by since the last earnings report for Humana (HUM) . Shares have added about 13.1% in that time frame, outperforming the S&P 500. Will the recent positive trend continue leading up to its next earnings release, or is Humana due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important catalysts. Premium Growth Propels Humana to Easy Q1 Earnings Beat Human ...

Humana (HUM) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near future.Over the past month, shares of this health insurer have returned -0.7%, compared to the Zacks S&P 500 composite's -4.1% change. During this period, the Zacks Medical - HMOs industry, which Humana falls in, has lost 3.7%. The key question now is: What could be the stock's future direction?Although media re ...

Key PointsHealth insurance giant Humana reported Q1 2024 EPS of $7.23, beating consensus estimates by $1.11 as revenues rose 10.7% YoY.Humana revised its 2024 GAAP EPS guidance down to $13.93 from $14.87 and adjusted EPS down to $16.00 from the $16.13 consensus.Humana noted that the $6.00 to $10.00 adjusted EPS for 2025 will have to be cut lower but won’t know by how much until later in 2024.5 stocks we like better than HumanaHealth insurer Humana Inc. NYSE: HUM reported its Q1 2024 earnings report to a les ...

An earnings report showing growth in key categories wasn't enough to lift investor sentiment on the company.Humana (HUM -3.66%) stock has not been a favorite of investors this year, and the health insurer's first-quarter earnings report published Wednesday morning did nothing to change that. Following its release the company's stock traded down, to the point where it closed Hump Day down by almost 4% in price. Meanwhile, the bellwether S&P 500 index did relatively better, trading more or less sideways on th ...